| 12281116 |
HTT modulators for treating Huntington's disease |
Celia Dominguez, Nikolay V. Plotnikov, Alan Findlay Haughan, Andrew J. Stott, Brett Cosgrove +6 more |
2025-04-22 |
|
| 12083121 |
Substituted piperazines as KRAS G12C inhibitors |
John Gordon Allen, Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee +21 more |
2024-09-10 |
$469,902,000 |
| 12083108 |
Compounds for targeting mutant huntingtin protein and uses thereof |
Celia Dominguez, Jonathan Bard, Matthew Lee, Michael Prime, Samuel Coe |
2024-09-10 |
|
| 12036292 |
Heterobiaryl compounds and imaging agents for imaging huntingtin protein |
Celia Dominguez, Xuemei Chen, John E. Mangette |
2024-07-16 |
|
| 11992535 |
Compounds and probes for imaging huntingtin protein |
Matthew Lee, Celia Dominguez, Peter David Johnson, Christopher John Brown, Sarah Hayes +3 more |
2024-05-28 |
|
| 11918662 |
Heterocyclic compounds and imaging agents for imaging huntingtin protein |
Matthew Lee, Celia Dominguez, Peter David Johnson, Catherine Jane Greenaway, Kanika Khurana +2 more |
2024-03-05 |
|
| 11905281 |
KRAS G12C inhibitors and methods of using the same |
Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee, David John Kopecky +9 more |
2024-02-20 |
$392,349,000 |
| 11806346 |
HTT modulators for treating Huntington's disease |
Celia Dominguez, Elizabeth M. Doherty, Matthew Lee, Mark Stuart Chambers, Karine Fabienne Malagu +7 more |
2023-11-07 |
|
| 11766436 |
KRAS G12C inhibitors and methods of using the same |
John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more |
2023-09-26 |
$282,576,000 |
| 11389438 |
Compounds for targeting mutant huntingtin protein and uses thereof |
Celia Dominguez, Jonathan Bard, Matthew Lee, Michael Prime, Samuel Coe |
2022-07-19 |
|
| 11285156 |
Substituted piperazines as KRAS G12C inhibitors |
John Gordon Allen, Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee +21 more |
2022-03-29 |
$231,793,000 |
| 11279742 |
Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
Haitao Wang, Yong Du, Rui Zhang, Jing Xu |
2022-03-22 |
|
| 11090304 |
KRAS G12C inhibitors and methods of using the same |
John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more |
2021-08-17 |
$335,995,000 |
| 11028398 |
Fusion proteins having mutated immunoglobulin hinge region |
Haitao Wang, Yong Du, Rui Zhang, Jing Xu |
2021-06-08 |
|
| 11021493 |
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use |
Jennifer R. Allen, Matthew P. Bourbeau, James Brown, Ning Chen, Michael J. Frohn +6 more |
2021-06-01 |
$258,451,000 |
| 10538565 |
Method of treating diseases with recombinant human interferon-like proteins |
Haitao Wang, Chunsheng Mao, Jizhi Li, Ling Wang, Yong Du +2 more |
2020-01-21 |
|
| 10519146 |
KRAS G12C inhibitors and methods of using the same |
Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee, David John Kopecky +9 more |
2019-12-31 |
$319,046,000 |
| 10246429 |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Jennifer R. Allen, Albert Amegadzie, Matthew P. Bourbeau, James Brown, Ning Chen +6 more |
2019-04-02 |
$473,856,000 |
| 10233223 |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
Haitao Wang, Yong Du, Rui Zhang, Jing Xu |
2019-03-19 |
|
| 10117949 |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
Haitao Wang, Yong Du, Rui Zhang, Jing Xu |
2018-11-06 |
|
| 9982028 |
Recombinant human interferon-like proteins |
Haitao Wang, Chunsheng Mao, Jizhi Li, Ling Wang, Yong Du +2 more |
2018-05-29 |
|
| 9550762 |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Jennifer R. Allen, Albert Amegadzie, Matthew P. Bourbeau, James Brown, Jian Chen +21 more |
2017-01-24 |
$492,282,000 |
| 9375487 |
Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
Haitao Wang, Yong Du, Rui Zhang, Jing Xu |
2016-06-28 |
|
| 9234022 |
Recombinant human interferon-like proteins and method of treatment using them |
Haitao Wang, Chunsheng Mao, Jizhi Li, Ling Wang, Yong Du +2 more |
2016-01-12 |
|
| 9066954 |
Fused heterocyclic derivatives and methods of use |
Brian K. Albrecht, David Bauer, Steven Bellon, Christiane M. Bode, Shon Booker +16 more |
2015-06-30 |
$523,879,000 |